Redbud enters biomanufacturing collaboration with industry leaders
Redbud is excited to join two collaborative development projects in biomanufacturing. Led by scientists at MIT and Villanova–and alongside partners at Genentech, Merck, and Millipore Sigma–projects include a transcriptome-based model for improved CAR-T therapy and a nanofluidic platform for bioprocess monitoring. These projects are part of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to address challenges in biomanufacturing and personalized medicine.
For more information, visit the NIIMBL project announcement page.
400 Park Offices Dr.
Suite 301
RTP NC 27709
In The News
Product Update
Our newest cartridge and instrument is up and running. This marks a significant milestone: NAxtract now processes eight samples, where our prototype processed just
one. These new instruments are going through verification and validation now, with deliveries scheduled for early next year.